Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Suppression of Tumorigenicity 2 (ST2) ELISA Kit-Sandwich

Cat. No.EK5F1

Product TypeAnimal Immunoassay Kits

Size

Product Overview

BioVenic Mouse Suppression of Tumorigenicity 2 (ST2) ELISA Kit-Sandwich is designed for the quantitative determination of Mouse ST2 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich
Specificity The assay kit is specific for Mouse Suppression of Tumorigenicity 2 (ST2).
Target Species Mouse
Species Reactivity Mouse
Detection Range 0.17-10 ng/mL
Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 12%
Assay Time Around 90 min
Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Suppression of Tumorigenicity 2 (ST2) is a member of interleukin-1 receptor family and has two key isoforms: the ST2 ligand (ST2L) and soluble ST2 (sST2). The ST2L is a transmembrane receptor, while sST2 circulates in the bloodstream as a soluble receptor. Although ST2 is primarily considered a pro-inflammatory factor, it may have the ability to inhibit tumor formation under certain circumstances. Studies in mice have demonstrated that those lacking the ST2 gene exhibited increased cardiac fibrosis and a greater cardiomyocyte cross-sectional area following transverse aortic constriction, compared to mice possessing the ST2 gene.

Target/Biomarker Mouse ST2
Target Synonym ST2; IL1RL1

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Ip, Christina et al. "Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis." International journal of cardiology. Heart & vasculature vol. 37 100887. 18 Oct. 2021.
Inquiry Basket